CAFFEINE CLEARANCE AND BIOTRANSFORMATION IN PATIENTS WITH CHRONIC LIVER-DISEASE

被引：29

作者：

SCOTT, NR

STAMBUK, D

CHAKRABORTY, J

MARKS, V

MORGAN, MY

机构：

[1] ROYAL FREE HOSP,ACAD DEPT MED,LONDON,ENGLAND

[2] UNIV SURREY,DEPT BIOCHEM,GUILDFORD GU2 5XH,SURREY,ENGLAND

来源：

CLINICAL SCIENCE | 1988年 / 74卷 / 04期

关键词：

D O I：

10.1042/cs0740377

中图分类号：

R-3 [医学研究方法]; R3 [基础医学];

学科分类号：

1001 ;

摘要：

引用

页码：377 / 384

页数：8

共 22 条

[1]

ALDRIDGE A, 1979, CLIN PHARMACOL THER, V25, P447

[2]

ARNAUD MJ, 1981, 9TH INT C SCI TECHN, P385

[3]

Barone J.J., 1984, CAFFEINE PERSPECTIVE, P59

[4] CAFFEINE DISPOSITION AFTER ORAL DOSES [J].

BONATI, M ;

LATINI, R ;

GALLETTI, F ;

YOUNG, JF ;

TOGNONI, G ;

GARATTINI, S .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 1982, 32 (01) :98-106

[5]

CALLAHAN MM, 1982, DRUG METAB DISPOS, V10, P417

[6]

CONN HO, 1977, GASTROENTEROLOGY, V72, P573

[7] IMPAIRED ELIMINATION OF CAFFEINE IN CIRRHOSIS [J].

DESMOND, PV ;

PATWARDHAN, RV ;

JOHNSON, RF ;

SCHENKER, S .

DIGESTIVE DISEASES AND SCIENCES, 1980, 25 (03) :193-197

[8] DRUG-METABOLISM IN LIVER-DISEASE - ACTIVITY OF HEPATIC MICROSOMAL METABOLIZING ENZYMES [J].

FARRELL, GC ;

COOKSLEY, WGE ;

POWELL, LW .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 1979, 26 (04) :483-492

[9]

GRYGIEL JJ, 1979, CLIN PHARMACOL THER, V26, P660

[10]

PARSONS WD, 1978, CLIN PHARMACOL THER, V24, P40

← 1 2 3 →